Abstract
dl-Ethylketazocine (EKC, 0.01 mg/kg) and saline were established as discriminative stimuli for food-maintained responding in macaque monkeys. Thirty consecutive presses on a right or left lever were reinforced with food, contingent on whether EKC or saline were administered before the session. For tests of antagonism, naltrexone, or UM 979 [(l)-5,9-alpha-dimethyl-2-(3-furylmethyl)-2′-hydroxy-6,7-benzomorphan] was administered concomitantly with EKC,dl-cyclazocine, or nalorphine. Both antagonists blocked completely the EKC discriminative stimulus. The antagonism of the stimulus and rate-altering effects of EKC was surmountable, with considerable intersubject variability in the magnitude of the EKC dose increase required to overcome the blockade. Cyclazocine and nalophine, mixed agonist-antagonist opioids that share stimulus properties with EKC, were also susceptible to antagonism. Naltrexone antagonized completely the EKC stimulus effects of nalorphine; naltrexone and UM 979 antagonized completely the EKC stimulus effects of cyclazocine. Naltrexone antagonism of the cyclazocine stimulus was not surmountable, due to a lack of antagonism of the rate-decreasing effects of high cyclazocine doses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Downs DA, Woods JH (1976) Morphine, pentazocine, and naloxone effects on responding under a multiple schedule of reinforcement in rhesus monkeys and pigeons. J Pharmacol Exp Ther 196:298–306
Goldberg SR, Morse WH, Goldberg DM (1976) Some behavioral effects of morphine, naloxone, and nalorphine in the squirrel monkey and the pigeon. J Pharmacol Exp Ther 196:625–636
Goldberg SR, Morse WH, Goldberg DM (1981) Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons. J Pharmacol Exp Ther 216:500–509
Harris RA (1980) Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior. J Pharmacol Exp Ther 213:497–503
Hein DW, Young AM, Herling S, Woods JH (1981) Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey. J Pharmacol Exp Ther 218:7–15
Herling S, Shannon HE (1982) Discriminative effects of ethylketazocine in the rat: Stereospecificity and antagonism by naloxone. Life Sci 31:2371–2374
Herling S, Woods JH (1981) Discriminative stimulus effects of narcotics: Evidence for multiple receptor-mediated actions. Life Sci 28:1571–1584
Hirschhorn ID (1977) Pentazocine, cyclazocine, and nalorphine as discriminative stimuli. Psychopharmacology 54:289–294
Holtzman SG (1982) Stimulus properties of opioids with mixed agonist and antagonist activity. Fed Proc 41:2328–2332
Leander JD (1982) Effects of ketazocine, ethylketazocine and phenazocine on schedule-controlled behavior: Antagonism by naloxone. Neuropharmacology 21:923–928
McMillan DE, Wolf PS, Carchman RA (1970) Antagonism of the behavioral effects of morphine and methadone by narcotic antagonists in the pigeon. J Pharmacol Exp Ther 175:443–458
Roemer D, Buscher H, Hill RC, Maurer R, Petcher TJ, Welle HBA, Bakel HCCK, Akkerman AM (1980) Bremazocine: A potent, long-acting opiatekappa-agonist. Life Sci 27:971–978
Rosecrans JA, Chance WR, Spencer RM (1978) The discriminative stimulus properties of cyclazocine: Generalization studies involving nalorphine, morphine, and LSD. Res Commun Chem Pathol Pharmacol 20:221–237
Schaefer GJ, Holtzman SG (1978) Discriminative effects of cyclazocine in the squirrel monkey. J Pharmacol Exp Ther 205:291–301
Shearman GT, Herz A (1982) Evidence that the discriminative stimulus properties of fentanyl and ethylketazocine are mediated by an interaction with different opiate receptors. J Pharmacol Exp Ther 221:735–739
Snell D, Harris RA (1982) Interactions between narcotic agonists, partial agonists and antagonists evaluated by punished and unpunished behavior in the rat. Psychopharmacology 76:177–181
Tang AH, Code RA (1983) Discriminative stimulus properties of nalorphine in the rhesus monkey. J Pharmacol Exp Ther 227:563–569
Teal JJ, Holtzman SG (1980a) Discriminative stimulus effects of cyclazocine in the rat. J Pharmacol Exp Ther 212:368–376
Teal, JJ, Holtzman SG (1980b) Discriminative stimulus effects of prototypic opiate receptor agonists in monkeys. Eur J Pharmacol 68:1–10
Teal JJ, Holtzman SG (1980c) Stereoselectivity of the stimulus effects of morphine and cyclazocine in the squirrel monkey. J Pharmacol Exp Ther 215:369–376
White JM, Holtzman SG (1981) Three-choice drug discrimination in the rat: Morphine, cyclazocine and saline. J Pharmacol Exp Ther 217:254–262
Young AM, Stephens KR, Hein DW, Woods JH (1984) Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. J Pharmacol Exp Ther 229:118–126
Young AM, Woods JH (1982) Limitations on the antagonistic actions of opioid antagonists. Fed Proc 41:2333–2338
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Young, A.M., Stephens, K.R. Antagonism of the discriminative effects of ethylketazocine, cyclazocine, and nalorphine in macaques. Psychopharmacology 84, 356–361 (1984). https://doi.org/10.1007/BF00555213
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00555213